Biosynthetic Glucagon
- Generic Name
- Biosynthetic Glucagon
- Brand Names
- -
- Drug Type
- -
- Chemical Formula
- -
- CAS Number
- -
- Unique Ingredient Identifier
- -
- Indication
1.用于治疗接受胰岛素治疗的糖尿病患者发生的严重低血糖反应。
2.进行胃肠道检查时用于暂时抑制肠道蠕动。
3.评估糖尿病患者的胰岛β细胞的最大分泌情况。
- Associated Conditions
- -
- Associated Therapies
- -
A Stable Glucagon Analog Administered by a Bihormonal Closed Loop System
- First Posted Date
- 2022-07-12
- Last Posted Date
- 2024-01-03
- Lead Sponsor
- Inreda Diabetic B.V.
- Registration Number
- NCT05454709
- Locations
- 🇳🇱
ZGT hospital, Almelo, Overijssel, Netherlands
Low-Dose Glucagon and Advanced Hybrid Closed-Loop System for Prevention of Exercise-Induced Hypoglycaemia in People With Type 1 Diabetes
- First Posted Date
- 2022-05-18
- Last Posted Date
- 2024-12-03
- Lead Sponsor
- Steno Diabetes Center Copenhagen
- Target Recruit Count
- 10
- Registration Number
- NCT05379686
- Locations
- 🇩🇰
Steno Diabetes Center Copenhagen, Herlev, Denmark
Low-dose Glucagon for Prevention of Exercise-Induced Hypoglycemia in People With Type 1 Diabetes
- First Posted Date
- 2021-10-13
- Last Posted Date
- 2023-12-05
- Lead Sponsor
- Steno Diabetes Center Copenhagen
- Target Recruit Count
- 22
- Registration Number
- NCT05076292
- Locations
- 🇩🇰
Sissel Banner Lundemose, Gentofte, Denmark
A Trial to Confirm the Efficacy and Safety of Dasiglucagon in the Treatment of Hypoglycemia in Type 1 Diabetes Subjects
- Conditions
- Interventions
- First Posted Date
- 2017-12-20
- Last Posted Date
- 2021-06-10
- Lead Sponsor
- Zealand Pharma
- Target Recruit Count
- 170
- Registration Number
- NCT03378635
- Locations
- 🇦🇹
Clinical Research Center, Medizinische Universität Graz, Graz, Austria
🇩🇪Profil, Neuss, Germany
🇺🇸ProSciento, Chula Vista, California, United States
A Trial to Evaluate the Immunogenicity of Dasiglucagon and GlucaGen in Patients With Type 1 Diabetes Mellitus
- Conditions
- Interventions
- First Posted Date
- 2017-07-13
- Last Posted Date
- 2021-05-04
- Lead Sponsor
- Zealand Pharma
- Target Recruit Count
- 112
- Registration Number
- NCT03216226
- Locations
- 🇨🇦
LMC Calgary, Calgary, Canada
🇦🇹CRC - Clinical Research Center, Medizinische Universität Graz, Graz, Austria
🇩🇪Diabeteszentrum Hamburg West, Gemeinschaftspraxis für Innere Medizin, Hamburg, Germany
Single Doses of ZP4207 Adm. sc to Hypoglycemic TD1 pt. to Describe the PK and PD of ZP4207 as Comp. to Marketed Glucagon
- First Posted Date
- 2016-01-21
- Last Posted Date
- 2016-06-15
- Lead Sponsor
- Zealand Pharma
- Target Recruit Count
- 81
- Registration Number
- NCT02660008
- Locations
- 🇩🇪
Profil Institut für Stoffwechselforschung GmbH, Neuss, Germany
Pharmacokinetics (PK) and Pharmacodynamics (PD) of Mayne Glucagon for Injection Compared With Glucagen® (Novo Nordisk) in Healthy Volunteers
- First Posted Date
- 2008-09-03
- Last Posted Date
- 2017-03-20
- Lead Sponsor
- Hospira, now a wholly owned subsidiary of Pfizer
- Target Recruit Count
- 28
- Registration Number
- NCT00745186
- Locations
- 🇬🇧
Charles River Laboratories, Edinburgh, United Kingdom
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.